Sutherland Everett Rand insider trades
Sutherland Everett Rand has filed 13 Form 4s with the SEC that we hold, for Krystal Biotech, Inc. (KRYS) (Director), Upstream Bio, Inc. (UPB) (Chief Executive Officer, Director), ALLK (Director) and TBIO (President). Across all of them we count 0 purchases worth $0 and 3 sales worth $43.7K reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($43.7K). The largest single trade was a sale of 2,093 shares of Upstream Bio, Inc. worth $19.4K, dated 2026-03-16. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-14 and the latest 2026-09-17.
Krystal Biotech, Inc. (KRYS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Upstream Bio, Inc. (UPB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-16 | S, sale reported on Form 4 | 2,093 | $19.4K | 2026-03-17 |
| 2026-06-16 | S, sale reported on Form 4 | 2,095 | $12.8K | 2026-06-17 |
| 2026-09-16 | S, sale reported on Form 4 | 2,095 | $11.5K | 2026-09-17 |
ALLK
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TBIO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1852880) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms